Previous studies in human rheumatoid arthritis and RP patients and the collagen-induced arthritis models have shown antibody responses to a variety of collagens, particularly CII [5,7], as well as cartilage matrix proteins such as matrilin-1 [8], especially during the acute phase of the disease. The gene discussed is MATN1; the disease is arthritic joint disease.